Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu

抗体多样性和基因组稳定性的研究:激活诱导的调节

基本信息

  • 批准号:
    8374091
  • 负责人:
  • 金额:
    $ 4.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-11-24 至 2013-11-23
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Activation-induced deaminase (AID) is an enzyme that mutates genes for antibodies in vertebrates. These AID-mediated mutations are necessary for an organism to generate specific antibodies to recognize and eradicate great varieties of microbial infections. However, if AID is not properly regulated, it can change DNA sequences of genes important for normal cell functions and cause diseases. Indeed, some lymphomas and leukemias are caused by abnormal activities of AID. How AID can change DNA sequences only in antibody genes but not in other genes is poorly understood. Recently, the catenin 2 like 1 protein (CTNNBL1) has been found to physically interact with AID. Little is known for the physiologic function of CTNNBL1. However, the interaction with CTNNBL1 is required for AID to change DNA sequences specifically in the antibody genes. In this study, a combination of high throughput approaches including next-generation sequencing and microarray analyses and targeted biochemical and immunologic analyses will be used to investigate how AID specifically mutate antibody genes, particularly what genomic regions are accessible to AID, both in the presence and in the absence of CTNNBL1. These experiments will also detect any alterations in transcription and splicing caused by the absence of CTNNBL1, and thereby shed lights on normal cellular functions of CTNNBL1. Mass spectrometry, mutagenic analyses and immunologic experiments will be performed to determine the molecular details of the interaction between AID and CTNNBL1 as well as to elucidate the mechanisms by which CTNNBL1 regulates the targeted activity of AID. It is anticipated that results from this study will be highly relevant for understanding the mechanisms underlying the generation of antibody diversity, and in the creation of new therapeutic strategies to minimize genomic disorders and cancers.
描述(由申请人提供):激活诱导脱氨酶(AID)是一种使脊椎动物抗体基因突变的酶。这些艾滋病介导的突变对于生物体产生识别和根除多种微生物感染的特异性抗体是必要的。然而,如果AID没有得到适当的调节,它可以改变对正常细胞功能重要的基因的DNA序列并导致疾病。事实上,一些淋巴瘤和白血病是由AID的异常活动引起的。为什么AID只能改变抗体基因的DNA序列,而不能改变其他基因的DNA序列,人们对此知之甚少。最近,catenin 2 like 1蛋白(CTNNBL1)被发现与AID发生物理相互作用。目前对CTNNBL1的生理功能知之甚少。然而,AID需要与CTNNBL1相互作用才能特异性地改变抗体基因中的DNA序列。在这项研究中,将结合高通量方法,包括下一代测序和微阵列分析,以及靶向生化和免疫学分析,来研究AID如何特异性地突变抗体基因,特别是在CTNNBL1存在和不存在的情况下,AID可进入的基因组区域。这些实验还将检测由于CTNNBL1缺失而引起的转录和剪接的任何改变,从而揭示CTNNBL1的正常细胞功能。将通过质谱分析、诱变分析和免疫学实验来确定AID与CTNNBL1相互作用的分子细节,并阐明CTNNBL1调控AID靶向活性的机制。预计这项研究的结果将对理解抗体多样性产生的机制以及创造新的治疗策略以最大限度地减少基因组疾病和癌症具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yee Ling Wu其他文献

Molecular basis of complement C1r deficiency in a male African American patient with systemic lupus erythematosus
  • DOI:
    10.1016/j.molimm.2010.05.072
  • 发表时间:
    2010-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Yee Ling Wu;Blake Brookshire;Chack-Yung Yu;Frank Arnett
  • 通讯作者:
    Frank Arnett
Low gene copy-number of complement C4A, the presence of HLA-DR3, and the presence of HLA-DR2 are independent and additive risk factors for human systemic lupus erythematosus
  • DOI:
    10.1016/j.molimm.2010.05.259
  • 发表时间:
    2010-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Yee Ling Wu;Emeli Lundstrom;Chau-Ching Liu;Yan Yang;Iva Gunnarsson;Elisabet Svenungsson;Bi Zhou;Karla N. Jones;Haikady N. Nagaraja;Gloria C. Higgins;Charles Spencer;Hermine Brunner;Dan J. Birmingham;Brad H. Rovin;Betty P. Tsao;Joseph M. Ahearn;Lee A. Hebert;Leonid Padyukov;C. Yung Yu
  • 通讯作者:
    C. Yung Yu
Lung-resident memory B cells maintain allergic IgE responses in the respiratory tract
肺驻留记忆 B 细胞维持呼吸道中的过敏性 IgE 反应
  • DOI:
    10.1016/j.immuni.2025.03.001
  • 发表时间:
    2025-04-08
  • 期刊:
  • 影响因子:
    26.300
  • 作者:
    Alexander J. Nelson;Bruna K. Tatematsu;Jordan R. Beach;Dorothy K. Sojka;Yee Ling Wu
  • 通讯作者:
    Yee Ling Wu

Yee Ling Wu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yee Ling Wu', 18)}}的其他基金

Development of B cell memory in allergic asthma
过敏性哮喘中 B 细胞记忆的发展
  • 批准号:
    10503760
  • 财政年份:
    2022
  • 资助金额:
    $ 4.61万
  • 项目类别:
Development of B cell memory in allergic asthma
过敏性哮喘中 B 细胞记忆的发展
  • 批准号:
    10642902
  • 财政年份:
    2022
  • 资助金额:
    $ 4.61万
  • 项目类别:
Investigation of memory B cell response in asthmatic lungs.
哮喘肺部记忆 B 细胞反应的研究。
  • 批准号:
    10413232
  • 财政年份:
    2021
  • 资助金额:
    $ 4.61万
  • 项目类别:
Investigation of memory B cell response in asthmatic lungs.
哮喘肺部记忆 B 细胞反应的研究。
  • 批准号:
    10303811
  • 财政年份:
    2021
  • 资助金额:
    $ 4.61万
  • 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
  • 批准号:
    8591624
  • 财政年份:
    2010
  • 资助金额:
    $ 4.61万
  • 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
  • 批准号:
    8002358
  • 财政年份:
    2010
  • 资助金额:
    $ 4.61万
  • 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
  • 批准号:
    8125086
  • 财政年份:
    2010
  • 资助金额:
    $ 4.61万
  • 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
  • 批准号:
    8409854
  • 财政年份:
    2010
  • 资助金额:
    $ 4.61万
  • 项目类别:
Studies of Antibody Diversity and Genome Stability: Regulation of Activation-Indu
抗体多样性和基因组稳定性的研究:激活诱导的调节
  • 批准号:
    8128051
  • 财政年份:
    2010
  • 资助金额:
    $ 4.61万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 4.61万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 4.61万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 4.61万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 4.61万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 4.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了